干细胞治疗女性压力性尿失禁的研究进展

汪成合, 陈忠. 干细胞治疗女性压力性尿失禁的研究进展[J]. 临床泌尿外科杂志, 2014, 29(5): 457-460. doi: 10.13201/j.issn.1001-1420.2014.05.031
引用本文: 汪成合, 陈忠. 干细胞治疗女性压力性尿失禁的研究进展[J]. 临床泌尿外科杂志, 2014, 29(5): 457-460. doi: 10.13201/j.issn.1001-1420.2014.05.031
WANG Chenghe, CHEN Zhong. Research progress of stem cell therapy in female stress urinary incontinence[J]. J Clin Urol, 2014, 29(5): 457-460. doi: 10.13201/j.issn.1001-1420.2014.05.031
Citation: WANG Chenghe, CHEN Zhong. Research progress of stem cell therapy in female stress urinary incontinence[J]. J Clin Urol, 2014, 29(5): 457-460. doi: 10.13201/j.issn.1001-1420.2014.05.031

干细胞治疗女性压力性尿失禁的研究进展

详细信息
    通讯作者: 陈忠,E-mail:chenzhongtj@126.com
  • 中图分类号: R694.54

Research progress of stem cell therapy in female stress urinary incontinence

More Information
  • 压力性尿失禁(SUI)是成年女性常见的泌尿系统疾病,给患者生活、工作和社会活动带来极大的影响。目前悬吊带术治疗SUI较成熟,微创简便,疗效确切,但可能出现并发症或者疾病复发。尿道周围注射填充剂,如牛胶原蛋白,远期效果不理想。干细胞是近年来研究的热点,有学者已尝试用其治疗SUI,特别是在大鼠SUI模型中研究较多,经尿道周围注射干细胞,如骨髓来源干细胞,肌肉来源干细胞和脂肪来源干细胞等,其可分化为平滑肌细胞等,提高大鼠尿道括约肌单位的功能,并促进神经细胞再生;注射的干细胞还可旁分泌多种因子,促进尿道组织再生,多种机制共同作用恢复尿道生理性的尿流控制能力。该治疗方法在临床开展较少,但仅有的数据也表明,在超声引导下经尿道周围注射干细胞能明显提高SUI患者的预后,改善排尿状况。
  • 加载中
  • [1]

    Wu G, Song Y, Zheng X, et al.Adipose-derived stromal cell transplantation for treatment of stress urinary incontinence[J].Tissue Cell, 2011, 43 (4):246-253.

    [2]

    Pollard M E, Morrisroe S, Anger J T.Outcomes of pregnancy following surgery for stress urinary incontinence:a systematic review[J].J Urol, 2012, 187 (6):1966-1970.

    [3]

    Shirvan M K, Alamdari D H, Mahboub M D, et al.A novel cell therapy for stress urinary incontinence, short-term outcome[J].Neurourol Urodyn, 2013, 32 (4):377-382.

    [4]

    Koike Y, Furuta A, Suzuki Y, et al.Pathophysiology of urinary incontinence in murine models[J].Int J Urol, 2013, 20 (1):64-71.

    [5]

    Rortveit G, Hannestad Y S, Daltveit A K, et al.Ageand type-dependent effects of parity on urinary incontinence:the Norwegian EPINCONT study[J].Obstet Gynecol, 2001, 98 (6):1004-1010.

    [6]

    Giberti C, Gallo F, Schenone M, et al.Stem cell therapy for male urinary incontinence[J].Urol Int, 2012.

    [7]

    Gräs S, Lose G.The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence[J].Acta Obstet Gynecol Scand, 2011, 90 (8):815-824.

    [8]

    Li G Y, Zhou F, Gong Y Q, et al.Activation of VEGF and ERK1/2and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model[J].Urology, 2012, 80 (4):953.e1-e8.

    [9]

    Allahverdiyev A M, Baydar S Y, Bagirova M, et al.Microcapillary culture method:a novel tool for in vitro expansion of stem cells from scarce sources[J].Arch Med Res, 2012, 43 (6):423-430.

    [10]

    Corcos J, Loutochin O, Campeau L, et al.Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence[J].Neurourol Urodyn, 2011, 30 (3):447-455.

    [11]

    Kim S O, Na H S, Kwon D, et al.Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model[J].Urol Int, 2011, 86 (1):110-116.

    [12]

    Chancellor M B, Yokoyama T, Tirney S, et al.Preliminary results of myoblast injection into the urethra and bladder wall:apossible method for the treatment of stress urinary incontinence and impaired detrusor contractility[J].Neurourol Urodyn, 2000, 19 (3):279-287.

    [13]

    Lee J Y, Paik S Y, Yuk S H, et al.Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves[J].Mol Cells, 2004, 18 (3):309-313.

    [14]

    Chermansky C J, Tarin T, Kwon D D, et al.Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency[J].Urology, 2004, 63 (4):780-785.

    [15]

    Tabit C J, Slack G C, Fan K, et al.Fat grafting versus adipose-derived stem cell therapy:distinguishing indications, techniques, and outcomes[J].Aesthetic Plast Surg, 2012, 36 (3):704-713.

    [16]

    Goldman H B, Sievert K D, Damaser M S.Will we ever use stem cells for the treatment of SUI?ICI-RS 2011[J].Neurourol Urodyn, 2012, 31 (3):386-389.

    [17]

    Carr L K, Steele D, Steele S, et al.1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence[J].Int Urogynecol J Pelvic Floor Dysfunct, 2008, 19 (6):881-883.

    [18]

    Strasser H, Marksteiner R, Margreiter E, et al.Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women:a randomised controlled trial[J].Lancet, 2007, 369 (9580):2179-2186.

    [19]

    Lin C S, Lue T F.Stem cell therapy for stress urinary incontinence:a critical review[J].Stem Cells Dev, 2012, 21 (6):834-843.

    [20]

    Zhao W, Zhang C, Jin C, et al.Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model[J].Eur Urol, 2011, 59 (1):155-163.

  • 加载中
计量
  • 文章访问数:  48
  • PDF下载数:  24
  • 施引文献:  0
出版历程
收稿日期:  2013-06-29

目录